ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 726 for:    (elderly OR senior) AND incontinence AND (woman OR women OR female)

Comparing Approaches to Treat Older Adult Women's Urge Incontinence: Pilot Feasibility and Randomized Controlled Trial (SHUW)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03176901
Recruitment Status : Active, not recruiting
First Posted : June 6, 2017
Last Update Posted : June 6, 2017
Sponsor:
Information provided by (Responsible Party):
Katarina Felsted, University of Utah

Brief Summary:
The purpose of this study is to examine the feasibility of conducting a pilot randomized controlled trial comparing mindfulness-based stress reduction with the health enhancement program on symptoms of urinary urge incontinence in older adult women, and to establish preliminary efficacy of these two approaches on symptoms of urinary urge incontinence.

Condition or disease Intervention/treatment Phase
Urinary Incontinence, Urge Urinary Incontinence in Old Age Behavioral: Mindfulness-Based Stress Reduction Behavioral: Health Enhancement Program Not Applicable

Detailed Description:

The overarching goal of this research is to evaluate potential treatment options for older women with symptoms of urinary urge incontinence, with a specific focus on Mindfulness-Based Stress Reduction, a promising therapeutic approach in preliminary studies and one increasingly used to treat symptoms associated with brain-visceral interactions. Feasibility and preliminary efficacy will be tested in two randomized study arms: a Mindfulness-Based Stress Reduction intervention group and a Health Enhancement Program intervention comparison group.

This research study will explore the feasibility and preliminary efficacy of treating urinary urge incontinence in older adult women with mindfulness-based stress reduction in comparison to the health enhancement program through a randomized controlled pilot study. Feasibility determinants will include both research feasibility (recruitment, retention, treatment fidelity) and intervention feasibility (acceptability, tolerability, treatment adherence). Clinical outcomes to evaluate preliminary intervention efficacy will include severity of urinary urge incontinence symptoms, bother of urinary urge incontinence symptoms, perceived stress, and perceived level of self-efficacy of self-management of urinary urge incontinence symptoms. Preliminary efficacy of the intervention will also be evaluated with the Patient Global Impression of Improvement, a process measure that rates the patient's "response of a condition to a therapy" (Ryan, n.d., p. 1).

This combined pilot feasibility study and randomized controlled trial will evaluate specific factors crucial to the success of a large trial to evaluate the effect of Mindfulness-Based Stress Reduction on urinary urge incontinence in older adult women. Moore (2011) recommended that the pilot study design parallel the future larger study, particularly when evaluating feasibility in the pilot study. The capacity for hypothesis testing, or establishing causal inference is limited in a pilot study due to insufficient power; however, the information from efficacy testing is vital in informing future larger scale clinical trials. This study will serve as a necessary step for the development of effectiveness trials of Mindfulness-Based Stress Reduction in treatment of urinary urge incontinence in older adult women by informing and guiding evaluation, implementation, and dissemination.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 25 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Two armed study with intervention and comparison groups running parallel to one another
Masking: Single (Participant)
Masking Description: This is a blinded, randomized controlled trial. Participants are blinded to condition.
Primary Purpose: Other
Official Title: Comparing Mindfulness-Based Stress Reduction With the Health Enhancement Program in the Treatment of Urinary Urge Incontinence in Older Adult Women: A Pilot Feasibility and Randomized Controlled Trial
Actual Study Start Date : February 3, 2017
Estimated Primary Completion Date : November 25, 2017
Estimated Study Completion Date : August 25, 2018

Arm Intervention/treatment
Experimental: Mindfulness-Based Stress Reduction
8 week manualized, standardized mindfulness-based stress reduction program taught by a certified Mindfulness-Based Stress Reduction instructor
Behavioral: Mindfulness-Based Stress Reduction
This experimental arm presents the actual Mindfulness-Based Stress Reduction program as developed in the late seventies and early eighties in its original eight week format

Active Comparator: Health Enhancement Program
8 week manualized, standardized health enhancement program, taught by a certified health education specialist
Behavioral: Health Enhancement Program
This active comparison arm presents the official Health Enhancement Program in its eight week format as developed by MacCoon in 2009.




Primary Outcome Measures :
  1. Number of potential participants contacted [ Time Frame: 10 weeks ]
    number of people who contacted PI during recruitment process, including the place they heard about the study

  2. number of enrolled participants completing the study [ Time Frame: 12 weeks ]
    number of participants who attended at least five of nine classes number of excused absences number of unexcused absences

  3. percentage of course content delivered during intervention [ Time Frame: 44 weeks ]
    weekly interventionist report on what was taught participants perception of course content delivered measured by a checklist of concepts covered in the weekly interventions at study completion

  4. positive or negative coded responses to the question "How did it go today?" [ Time Frame: 8 weeks ]
    data coded from two participants' responses after each class in each arm

  5. number of participants who completed each week's homework practice [ Time Frame: 8 weeks ]
    participants mark on homework practice log and submit weekly

  6. number of participants recruited for enrollment [ Time Frame: 10 weeks ]
    potential participants who were interested in the study

  7. number of potential participants who are eligible to enroll [ Time Frame: 10 weeks ]
    number of people who passed the screening process via calls or emails

  8. consent rate [ Time Frame: 10 weeks ]
    number of participants who are willing to sign consent document at enrollment interview; number who pass the Montreal Cognitive Assessment and are willing to sign consent document

  9. number of participants enrolled [ Time Frame: 10 weeks ]
    number of people who enrolled into the study

  10. number of dropouts due to stated distress from or dislike of either intervention experience (as opposed to someone needing to withdraw due to a family emergency or illness) [ Time Frame: 8 weeks ]
    participant self-report of what made the intervention challenging - why they were unable or unwilling to complete the course

  11. - number of minutes of homework practice each week [ Time Frame: 8 weeks ]
    totaled from daily numbers reported by participant


Secondary Outcome Measures :
  1. change in symptom severity [ Time Frame: 16 weeks, 6 months ]
    measured by the Incontinence Severity Index

  2. change in symptom bother [ Time Frame: 16 weeks, 6 months ]
    measured by the Overactive Bladder questionnaire, short form

  3. change in perceived stress [ Time Frame: 16 weeks, 6 months ]
    measured by the Perceived Stress Scale

  4. change in perceived self-efficacy [ Time Frame: 16 weeks, 6 months ]
    measured by the Geriatric Self Efficacy Index for Urinary Incontinence

  5. self report of rate and trajectory of change in participant impression of improvement [ Time Frame: 16 weeks, 6 months ]
    measured by the Patient Global Impression of Improvement



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years to 105 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   participants must self-identify as female to participate
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

The following eligibility criteria must be met for the potential participant to be considered for enrollment.

  • The study is enrolling older adult women, with urinary urge incontinence.
  • They cannot be currently treating their urinary urge incontinence with medication as this will confound results.
  • Women who have attempted more extreme treatments and are still experiencing urinary urge incontinence will not be considered as potential participants, as it is unlikely that mindfulness-based stress reduction would treat urinary urge incontinence that is refractory to that degree.
  • Participants must be English speaking, as the interventions and homework will be delivered in English.
  • postmenopausal women
  • Urge predominant urinary incontinence, defined as score of ≥ 3 (moderate to severe urinary incontinence) on the Incontinence Severity Index
  • Urge predominant urinary incontinence as determined by question 3 on the 3 Incontinence Questions. The 3 Incontinence Questions has been shown to be a quick and accurate way of diagnosing stress, urge or mixed incontinence in most cases
  • Has experienced urinary urge incontinence symptoms for at least three months
  • Committed to attend 8 weekly sessions and one half day retreat between weeks 6 and 7
  • No pharmacologic therapy for urinary urge incontinence within three weeks of enrollment and no plan to initiate such medications during the 8 week active treatment
  • If on hormone therapy or vaginal estrogen, plan to remain on it for the duration of the study; if not on it, no plan to initiate
  • No previous intradetrusor Botox injection for urinary urge incontinence and no plan to receive it during the intervention
  • No previous neurostimulation for urinary urge incontinence and no plan to receive it during the intervention English speaking
  • A score of >24 on the Montreal Cognitive Assessment

Exclusion Criteria:

The following exclusions are applied, as they could seriously limit participation or confound participant response to the intervention:

  • Predominantly stress, mixed, or other type of incontinence as determined by question 3 on the 3 Incontinence Questions
  • Currently taking medications for Alzheimer's disease or other dementias; these medications could interfere with their participation
  • Known neurologic disease acknowledged to impact bladder function including Parkinson's disease, spinal cord injury, or stroke affecting urinary control; these diseases provide cause for urinary urge incontinence and as such the participant would be unlikely to benefit from the intervention
  • Current symptomatic urinary tract infection that has not resolved prior to the start of intervention
  • Current bladder infection that has not resolved prior to the start of intervention
  • Use of an assistive device for ambulation (such as a cane, walker, or wheelchair) and feels that difficulties with bladder management are related to the slowed time in visiting the restroom ("Was urinary urge incontinence a problem before you began using the assistive device?")
  • Functionally incontinent, in other words, having a mental or physical condition that prevents a person from visiting the restroom in time
  • Ever diagnosed with interstitial cystitis
  • Self-report of vaginal bulge protruding outside of the vagina
  • Past participation in a formal program of mindfulness-based stress reduction
  • Substantial, uncorrected hearing loss
  • Substantial, uncorrected vision loss
  • Limitations that preclude completing study questionnaires or surveys, such as difficulties with reading and writing or a cognitive impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03176901


Locations
United States, Utah
University of Utah
Salt Lake City, Utah, United States, 84112
Sponsors and Collaborators
University of Utah
Investigators
Principal Investigator: Katarina F Felsted, MS University of Utah

Responsible Party: Katarina Felsted, Assistant Professor, University of Utah
ClinicalTrials.gov Identifier: NCT03176901     History of Changes
Other Study ID Numbers: 00095461
First Posted: June 6, 2017    Key Record Dates
Last Update Posted: June 6, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Katarina Felsted, University of Utah:
urinary urge incontinence
urinary incontinence
older adult women
older adults
mindfulness-based stress reduction
health enhancement program
feasibility
randomized controlled trial
complementary
integrative
therapies

Additional relevant MeSH terms:
Urinary Incontinence
Urinary Incontinence, Urge
Enuresis
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms
Behavioral Symptoms
Elimination Disorders
Mental Disorders